Cargando…

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study

OBJECTIVES: This study aims to analyze the incidence of Post-acute COVID-19 syndrome (PCS) and its components, and to evaluate the acute infection phase associated risk factors. METHODS: A prospective cohort study of adult patients who had recovered from COVID-19 (27th February to 29th April 2020) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Pérez, Oscar, Merino, Esperanza, Leon-Ramirez, Jose-Manuel, Andres, Mariano, Ramos, Jose Manuel, Arenas-Jiménez, Juan, Asensio, Santos, Sanchez, Rosa, Ruiz-Torregrosa, Paloma, Galan, Irene, Scholz, Alexander, Amo, Antonio, González-delaAleja, Pilar, Boix, Vicente, Gil, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802523/
https://www.ncbi.nlm.nih.gov/pubmed/33450302
http://dx.doi.org/10.1016/j.jinf.2021.01.004
_version_ 1783635774462230528
author Moreno-Pérez, Oscar
Merino, Esperanza
Leon-Ramirez, Jose-Manuel
Andres, Mariano
Ramos, Jose Manuel
Arenas-Jiménez, Juan
Asensio, Santos
Sanchez, Rosa
Ruiz-Torregrosa, Paloma
Galan, Irene
Scholz, Alexander
Amo, Antonio
González-delaAleja, Pilar
Boix, Vicente
Gil, Joan
author_facet Moreno-Pérez, Oscar
Merino, Esperanza
Leon-Ramirez, Jose-Manuel
Andres, Mariano
Ramos, Jose Manuel
Arenas-Jiménez, Juan
Asensio, Santos
Sanchez, Rosa
Ruiz-Torregrosa, Paloma
Galan, Irene
Scholz, Alexander
Amo, Antonio
González-delaAleja, Pilar
Boix, Vicente
Gil, Joan
author_sort Moreno-Pérez, Oscar
collection PubMed
description OBJECTIVES: This study aims to analyze the incidence of Post-acute COVID-19 syndrome (PCS) and its components, and to evaluate the acute infection phase associated risk factors. METHODS: A prospective cohort study of adult patients who had recovered from COVID-19 (27th February to 29th April 2020) confirmed by PCR or subsequent seroconversion, with a systematic assessment 10–14 weeks after disease onset. PCS was defined as the persistence of at least one clinically relevant symptom, or abnormalities in spirometry or chest radiology. Outcome predictors were analyzed by multiple logistic regression (OR; 95%CI). RESULTS: Two hundred seventy seven patients recovered from mild (34.3%) or severe (65.7%) forms of SARS-CoV-2 infection were evaluated 77 days (IQR 72–85) after disease onset. PCS was detected in 141 patients (50.9%; 95%CI 45.0–56.7%). Symptoms were mostly mild. Alterations in spirometry were noted in 25/269 (9.3%), while in radiographs in 51/277 (18.9%). No baseline clinical features behaved as independent predictors of PCS development. CONCLUSIONS: A Post-acute COVID-19 syndrome was detected in a half of COVID19 survivors. Radiological and spirometric changes were mild and observed in less than 25% of patients. No baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development.
format Online
Article
Text
id pubmed-7802523
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd on behalf of The British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-78025232021-01-13 Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study Moreno-Pérez, Oscar Merino, Esperanza Leon-Ramirez, Jose-Manuel Andres, Mariano Ramos, Jose Manuel Arenas-Jiménez, Juan Asensio, Santos Sanchez, Rosa Ruiz-Torregrosa, Paloma Galan, Irene Scholz, Alexander Amo, Antonio González-delaAleja, Pilar Boix, Vicente Gil, Joan J Infect Article OBJECTIVES: This study aims to analyze the incidence of Post-acute COVID-19 syndrome (PCS) and its components, and to evaluate the acute infection phase associated risk factors. METHODS: A prospective cohort study of adult patients who had recovered from COVID-19 (27th February to 29th April 2020) confirmed by PCR or subsequent seroconversion, with a systematic assessment 10–14 weeks after disease onset. PCS was defined as the persistence of at least one clinically relevant symptom, or abnormalities in spirometry or chest radiology. Outcome predictors were analyzed by multiple logistic regression (OR; 95%CI). RESULTS: Two hundred seventy seven patients recovered from mild (34.3%) or severe (65.7%) forms of SARS-CoV-2 infection were evaluated 77 days (IQR 72–85) after disease onset. PCS was detected in 141 patients (50.9%; 95%CI 45.0–56.7%). Symptoms were mostly mild. Alterations in spirometry were noted in 25/269 (9.3%), while in radiographs in 51/277 (18.9%). No baseline clinical features behaved as independent predictors of PCS development. CONCLUSIONS: A Post-acute COVID-19 syndrome was detected in a half of COVID19 survivors. Radiological and spirometric changes were mild and observed in less than 25% of patients. No baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development. Published by Elsevier Ltd on behalf of The British Infection Association. 2021-03 2021-01-12 /pmc/articles/PMC7802523/ /pubmed/33450302 http://dx.doi.org/10.1016/j.jinf.2021.01.004 Text en © 2021 Published by Elsevier Ltd on behalf of The British Infection Association. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Moreno-Pérez, Oscar
Merino, Esperanza
Leon-Ramirez, Jose-Manuel
Andres, Mariano
Ramos, Jose Manuel
Arenas-Jiménez, Juan
Asensio, Santos
Sanchez, Rosa
Ruiz-Torregrosa, Paloma
Galan, Irene
Scholz, Alexander
Amo, Antonio
González-delaAleja, Pilar
Boix, Vicente
Gil, Joan
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title_full Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title_fullStr Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title_full_unstemmed Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title_short Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
title_sort post-acute covid-19 syndrome. incidence and risk factors: a mediterranean cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802523/
https://www.ncbi.nlm.nih.gov/pubmed/33450302
http://dx.doi.org/10.1016/j.jinf.2021.01.004
work_keys_str_mv AT morenoperezoscar postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT merinoesperanza postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT leonramirezjosemanuel postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT andresmariano postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT ramosjosemanuel postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT arenasjimenezjuan postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT asensiosantos postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT sanchezrosa postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT ruiztorregrosapaloma postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT galanirene postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT scholzalexander postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT amoantonio postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT gonzalezdelaalejapilar postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT boixvicente postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT giljoan postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy
AT postacutecovid19syndromeincidenceandriskfactorsamediterraneancohortstudy